Skip to main content
IMNM logo
IMNM
(NASDAQ)
Immunome, Inc.
$19.66-- (--)
Loading... - Market loading

Immunome (IMNM) Stock Price & Financial Analysis

Immunome Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$19.85 - $21.67
52-Week High$27.65
52-Week Low$7.42
Open$19.94
Volume1.72M
Average Volume (3M)938.29K
Market Cap1.82B
Shares Outstanding87.35M
Price to Sales (P/S)262.77
Price to Book (P/B)2.88
EV/EBITDA-5.56
Revenue (TTM)6.94M
Net Income (TTM)-212.39M
Free Cash Flow (TTM)-206.85M
EPS (TTM)$-2.49
Profit Margin-3059.99%
Operating Margin-3084.76%
Return on Equity (ROE)-33.48%
Debt to Equity0.01
50-Day MA$22.02
200-Day MA$18.05
52-Week Change189.67%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Immunome

What is the current stock price for IMNM?

As of the latest trading session, IMNM stock trades at $21.53. The 52-week range is $7.42–$27.65, with a day range of $19.85–$21.67.

What is the P/E ratio for IMNM?

The P/E ratio (Price-to-Earnings) for IMNM is shown in the Key Statistics section. This valuation metric helps compare Immunome, Inc. to industry peers.

Does IMNM pay dividends?

Immunome does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IMNM?

Based on 8 analysts, the consensus for IMNM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IMNM?

Immunome's market capitalization is $1.88B, classifying it as a small-cap company. Immunome operates in the Healthcare sector within the Biotechnology industry.